Pulmonary fibrosis: Which patient should be admitted to the ICU and based on which criteria?;Fibrose pulmonaire: dans quels cas et sur quels critères envisager une admission en réanimation ?

Reanimation

Volumn 22, Issue 1, 2013, Pages 45-53

  Mullier, A ^a   Cottin, V ^b   Richard, J C ^a   Guerin C ^a  

^a CROIX ROUSSE HOSPITAL   (France)

^b LOUIS PRADEL HOSPITAL   (France)

Author keywords

Acute exacerbation; Acute respiratory failure; Idiopathic pulmonary fibrosis; Mechanical ventilation; Pulmonary hypertension

Indexed keywords

ARTICLE; DETERIORATION; DISEASE EXACERBATION; FIBROSING ALVEOLITIS; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; INTERPERSONAL COMMUNICATION; INTERSTITIAL LUNG DISEASE; LUNG FIBROSIS; LUNG TRANSPLANTATION; OUTCOME ASSESSMENT; PHYSICIAN; PULMONARY HYPERTENSION;

EID: 84879642783     PISSN: 16240693     EISSN: 19516959     Source Type: Journal    
DOI: 10.1007/s13546-012-0642-y     Document Type: Article

References (46)

1. ATS/ERS (2002) American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 165:277-304
2. Margaritopoulos GA, Romagnoli M, Poletti V, et al (2012) Recent advances in the pathogenesis and clinical evaluation of pulmonary fibrosis. Eur Respir Rev 21:48-56
3. Raghu G, Collard HR, Egan JJ, et al (2011) An official ATS/ ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183:788-824
4. Meyer KC, Raghu G, Baughman RP, et al (2012) An Official American Thoracic Society Clinical Practice Guideline: The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis in Interstitial Lung Disease. Am J Respir Crit Care Med 185:1004-1014
5. Harari S, Caminati A (2010) Update on diffuse parenchymal lung disease. Eur Resp Rev 19:97-108
6. Ley B, Collard HR, King TE Jr (2011) Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 183:431-440
7. Cottin V (2010) Interstitial lung disease: new challenges and evolving phenotypes. Eur Resp J 116:91-93
8. Sumikawa H, Johkoh T, Colby TV (2008) Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival. Am J Respir Crit Care Med 177:433-439
9. Raghu G (2011) Idiopathic pulmonary fibrosis: guidelines for diagnosis and clinical management have advanced from consensusbased in 2000 to evidence-based in 2011. Eur Respir J 37:743-746
10. King TE, Behr J, Brown KK (2008) BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 177:75-81
11. King TE Jr, Brown KK, Raghu G, et al (2012) BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 184: 92-99
12. King TE, Albera C, Bradford WZ (2009) Effect of interferon c-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial. Lancet 374:222-228
13. Raghu G, Brown KK, Costabel U (2008) Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo controlled trial. Am J Respir Crit Care Med 178:948-955
14. Daniels CE, Lasky JA, Limper AH (2010) Imatinib treatment for idiopathic pulmonary fibrosis. Randomized placebo-controlled trial results. Am J Respir Crit Care Med 181:604-610
15. Noble PW, Albera C, Bradford WZ, et al (2011) Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet 377:1760-1769
16. Taniguchi H, Ebina M, Kondoh Y (2010) Pirfenidone in idiopathic pulmonary fibrosis a phase III clinical trial in Japan. Eur Respir J 35:821-829
17. Demedts M, Behr J, Buhl R, et al (2005) High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 353:2229-2242
18. Raghu G, Anstrom KJ, King TE Jr, et al (2012) Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med 366:1968-1977
19. Wells AU, Behr J, Costabel U, et al (2012) Triple therapy in idiopathic pulmonary fibrosis: an alarming press release. Eur Respir J 39:805-806
20. Noth I, Anstrom KJ, Calvert SB, et al (2012) A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med 186:88-95
21. Zisman DA (2010) The STEP-IPF Trial: Sildenafil Trial Of Exercise Performance In Idiopathic Pulmonary Fibrosis. Am J Respi Crit Care Med 181:A3992
22. Tashkin DP, Elashoff R, Clements PJ (2007) Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. Am J Respir Crit Care Med 176:1026-1034
23. Bissler JJ, McCormack FX, Young LR (2008) Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med 358:140-151
24. McCormack FX, Inoue Y, Moss J, et al (2011) Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med 364:1595-1606
25. Akira M, Kozuka T, Yamamoto S (2008) Computed tomography findings in acute exacerbation of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 178:372-378
26. Daniels CE, Yi ES, Ryu JH (2008) Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis. Eur Respir J 32:170-174
27. Song JW, Hong SB, Lim CM, et al (2011) Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome. Eur Respir J 37:356-363
28. Simon-Blancal V, Freynet O, Nunes H, et al (2012) Acute exacerbation of idiopathic pulmonary fibrosis: outcome and prognostic factors. Respiration 83:28-35
29. Behr J, Ryu JH (2008) Pulmonary hypertension in interstitial lung disease. Eur Resp J 31:1357-1367
30. Blivet S, Philit F, Sab JM, et al (2001) Outcome of patients with idiopathic pulmonary fibrosis admitted to the ICU for respiratory failure. Chest 120:209-212
31. Stern JB, Mal H, Groussard O, et al (2001) Prognosis of patients with advanced idiopathic pulmonary fibrosis requiring mechanical ventilation for acute respiratory failure. Chest 120:213-219
32. Fumeaux T, Rothmeier C, Jolliet P (2001) Outcome of mechanical ventilation for acute respiratory failure in patients with pulmonary fibrosis. Intensive Care Med 27:1868-1874
33. Saydain G, Islam A, Afessa B, et al (2002) Outcome of patients with idiopathic pulmonary fibrosis admitted to the intensive care unit. Am J Respir Crit Care Med 166:839-842
34. Ambrosini V, Cancellieri A, Chilosi M, et al (2003) Acute exacerbation of idiopathic pulmonary fibrosis: report of a series. Eur Resp J 22:821-826
35. Al-Hameed FM, Sharma S (2004) Outcome of patients admitted to the intensive care unit for acute exacerbation of idiopathic pulmonary fibrosis. Can Respir J 11:117-122
36. Kim DS, Park JH, Park BK, et al (2006) Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features. Eur Resp J 27:143-150
37. Parambil JG, Myers JL, Aubry MC, Ryu JH (2007) Causes and prognosis of diffuse alveolar damage diagnosed on surgical lung biopsy. Chest 132:50-57
38. Fernández-Pérez ER, Yilmaz M, Jenad H, et al (2008) Ventilator settings and outcome of respiratory failure in chronic interstitial lung disease. Chest 133:1113-1119
39. Park IN, Kim DS, Shim TS, et al (2007) Acute exacerbations of interstitial pneumonia other than idiopathic pulmonary fibrosis. Chest 132:214-220
40. Rangappa P, Moran JL (2009) Outcomes of patients admitted to the intensive care unit with idiopathic pulmonary fibrosis. Crit Care Resusc 11:102-109
41. Mullier A, Bayle F, Bourdin G, et al (2012) Pronostic des fibroses pulmonaires interstitielles idiopathiques admises en réanimation pour insuffisance respiratoire aiguë. Réanimation 21:S109
42. Azoulay E, Mokart D, Lambert J, et al (2010) Diagnostic strategy for hematology and oncology patients with acute respiratory failure: randomized controlled trial. Am J Respir Crit Care Med 182:1038-1046
43. Tachikawa R, Tomii K, Ueda H, et al (2012). Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular diseases-related versus idiopathic. Respiration 83:20-27
44. Tachikawa R, Tomii K, Murase K, et al (2011) Therapeutic effect of direct hemoperfusion with a polymyxin B-immobilized fiber column in the treatment of HIV-negative severe pneumocystis pneumonia. Respiration 81:318-324
45. Hara S, Ishimoto H, Sakamoto N, et al (2011) Direct hemoperfusion using immobilized polymyxin B in patients with rapidly progressive interstitial pneumonias: a retrospective study. Respiration 81:107-117
46. Fuehner T, Kuehn C, Hadem J, et al (2012) Extracorporeal membrane oxygenation in awake patients as bridge to lung transplantation. Am J Respir Crit Care Med 185:763-768